What is claimed is:
1. A spark plug for an engine comprising;
a mounting member made of a conductive material which is mounted to an engine;
an insulator disposed inside the mounting member and formed with an axial hole;
a center electrode formed of a metal material and disposed in the axial hole of the insulator in a manner insulated from the mounting member; and
an earth electrode disposed so as to oppose to the center electrode,
at least one of said center electrode and earth electrode being formed as a base material having one surface to which a tip composed, as a discharge member, of a noble metal or alloy thereof is welded and fixed thereto through a fused portion,
wherein said fused portion between the tip and the base material has an area of a maximum sectional area portion of a size of not more than 1.5 times a sectional area of a portion of the tip positioned at a boundary portion to the fused portion, and the sectional area of the tip positioned at the boundary portion is not less than 2 mm2 and not more than 7 mm2.
2. A spark plug according to claim 1, wherein said fused portion has a minimum sectional area portion having an area of a size of not less than 0.6 time the sectional area of the tip positioned at the boundary portion to the fused portion.
3. A spark plug according to claim 1, wherein said base material has a sectional area, as a small sectional area portion, along one surface thereof, which has a size of not more than 1.5 times the sectional area of the portion of the tip positioned at the boundary portion to the fused portion, said small sectional area portion being formed so as to provide a formation length of not more than 2.0 mm in a direction normal to the one surface of said base material from the boundary portion between the base material and the fused portion.
4. A spark plug according to claim 1, wherein said tip is fixed to the one surface of the base material through a laser welding.
5. A spark plug according to claim 1, wherein said tip is formed of an alloy including Ir of not less than 50 weight %.
6. A spark plug for an engine comprising;
a mounting member made of a conductive material which is mounted to an engine;
an insulator disposed inside the mounting member and formed with an axial hole;
a center electrode formed of a metal material and disposed in the axial hole of the insulator in a manner insulated from the mounting member; and
an earth electrode disposed so as to oppose to the center electrode,
at least one of said center electrode and earth electrode being formed as a base material having one surface to which a tip composed, as a discharge member, of a noble metal or alloy thereof is welded and fixed thereto through a fused portion,
wherein said fused portion between the tip and the base material has a sectional area having shape and size substantially the same as those of a sectional area of a portion of the tip positioned at a boundary portion to the fused portion.
7. A spark plug according to claim 6, wherein said base material has a sectional area, as a same-shaped portion, along one surface thereof, which has shape and size substantially the same as those of the sectional area of the fused portion, said same-shaped portion being formed so as to provide a formation length of not more than 2.0 mm in a direction normal to the one surface of the base material from the boundary portion between the base material and the fused portion.
8. A spark plug according to claim 6, wherein said tip is fixed to the one surface of the base material through a laser welding.
9. A spark plug according to claim 6, wherein said tip is formed of an alloy including Ir of not less than 50 weight %.
10. A method of manufacturing a spark plug for an engine which comprises an insulator disposed inside a mounting member through which the spark plug is mounted to an engine, a center electrode formed of a metal material and disposed to the insulator and an earth electrode disposed so as to oppose to the center electrode, and in which at least one of said center electrode and earth electrode is formed as a base material having one surface to which a tip composed, as a discharge member, of a noble metal or alloy thereof is welded and fixed thereto through a fused portion,
said manufacturing method comprising the steps of;
welding the tip to the one surface of the base material; and
working the fused portion between the tip and the base material so as to provide a predetermined shape.
11. A spark plug manufacturing method according to claim 10, wherein said fused portion between the tip and the base material has an area of a maximum sectional area portion having a size of not more than 1.5 times a sectional area of a portion of the tip positioned at a boundary portion to the fused portion.
12. A spark plug manufacturing method according to claim 11, wherein the sectional area of the tip positioned at the boundary portion is not less than 2 mm2 and not more than 7 mm2.
13. A spark plug manufacturing method according to claim 10, wherein said fused portion between the tip and the base material has a sectional area having shape and size substantially the same as those of a sectional area of a portion of the tip positioned at a boundary portion to the fused portion.
14. A spark plug manufacturing method according to claim 10, wherein the fused portion and the base material adjacent to the fused portion is subjected to a shaping working so as to provide a predetermined shape of the base material.
15. A spark manufacturing method according to claim 10, wherein the tip is fixed to the one surface of the base material through a laser welding.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound according to formula I
wherein
X3 and X4 are selected from N and C, such that when X3 is N, X4 is C and when X3 is C, X4 is N;
P is selected from aryl and heteroaryl;
if m=1 then R1 is attached to P via a carbon atom on ring P at the meta-position of the ring P relative to the attachment point of P at X3, and if m=2 then R1 is attached to P via carbon atoms on ring P at the 2-, and 5-positions of the ring P;
R1 is selected from the group consisting of hydroxy, halo, nitro, C1-6alkylhalo, OC1-6alkylhalo, C1-6alkyl, OC1-6alkyl, C2-6alkenyl, OC2-6alkenyl, C2-6alkynyl, OC2-6alkynyl, C0-6alkylC3-6cycloalkyl, OC0-6alkylC3-6cycloalkyl, C0-6alkylaryl, OC0-6alkylaryl, CHO, (CO)R5, O(CO)R5, O(CO)OR5, O(CNR5)OR5, C1-6alkylOR5, OC2-6alkylOR5, C1-6alkyl(CO)R5, OC1-6alkyl(CO)R5, C0-6alkylCO2R5, OC1-6alkylCO2R5, C0-6alkylcyano, OC2-6alkylcyano, C0-6alkylNR5R6, OC2-6alkylNR5R6, C1-6alkyl(CO)NR5R6, OC1-6alkyl(CO)NR5R6, C0-6alkylNR5(CO)R6, OC2-6alkylNR5(CO)R6, C0-6alkylNR5(CO)NR5R6, C0-6alkylSR5, OC2-6alkylSR5, C0-6alkyl(SO)R5, OC2-6alkyl(SO)R5, C0-6alkylSO2R5, OC2-6alkylSO2R5, C0-6alkyl(SO2)NR5R6, OC2-6alkyl(SO2)NR5R6,C0-6alkylNR5(SO2)R6, OC2-6alkylNR5(SO2)R6, C0-6alkylNR5(SO2)NR5R6, OC2-6alkylNR5(SO2)NR5R6, (CO)NR5R6, O(CO)NR5R6, NR5OR6, C0-6alkylNR5(CO)OR6, OC2-6alkylNR5(CO)OR6, SO3R5 and a 5- or 6-membered ring containing one or more atoms independently selected from the group consisting of C, N, O and S;
X1 is selected from the group consisting of C2-3alkyl, C2-3alkenyl, NR3, O, S, CR3R4, SO, SO2
X2 is selected from the group consisting of a bond, CR3R4, O, S, NR3, SO, SO2
R3 and R4 are independently selected from a group consisting of hydrogen, hydroxy, C1-6alkyl, C0-6alkylcyano, oxo, \u2550NR5, \u2550NOR5, C1-4alkylhalo, halo, C1-4alkylC3-7cycloalkyl, C3-7cycloalkyl, O(CO)C1-4alkyl, (CO)C1-4alkyl, C1-4alkyl(SO)C0-4alkyl, C1-4alkyl(SO2)C0-4alkyl, (SO)C0-4alkyl, (SO2)C0-4alkyl, OC1-4alkyl, C1-4alkylOR5 and C0-4alkylNR5R6;
Q is either selected from triazole, piperazine, and imidazole, or else Q is any other 4-, 5-, 6-, or 7-membered heterocyclic ring containing one or more heteroatoms selected from N, O and S and is fused to a triazole ring;
R2 is selected from the group consisting of hydroxy, C0-6alkylcyano, \u2550NR5, \u2550O, \u2550NOR5, C1-4alkylhalo, halo, C1-6alkyl, C3-6cycloalkyl, C0-6alkylaryl, C0-6alkylheteroaryl, C0-6alkylcycloalkyl, C0-6alkylheterocycloalkyl, OC1-4alkyl, OC0-6alkylaryl, O(CO)C1-4alkyl, (CO)OC1-4alkyl, C0-4alkyl(S)C0-4alkyl, C1-4alkyl(SO)C0-4alkyl, C1-4alkyl(SO2)C0-4alkyl, (SO)C0-4alkyl, (SO2)C0-4alkyl, C1-4alkylOR5, C0-4alkylNR5R6 and a 5- or 6-membered ring containing one or more atoms independently selected from C, N, O and S, which ring may optionally be fused with a 5- or 6-membered ring containing one or more atoms independently selected from the group consisting of C, N and O and wherein said ring and said fused ring may be substituted by one or more A; and
any C1-6alkyl, aryl, or heteroaryl defined under R1, R2 and R3 may be substituted by one or more A; and
A is selected from the group consisting of hydrogen, hydroxy, halo, nitro, oxo, C0-6alkylcyano, C0-4alkylC3-6cycloalkyl, C1-6alkyl, \u2014OC1-6alkyl, C1-6alkylhalo, OC1-6alkylhalo, C2-6alkenyl, C0-3 alkylaryl, C0-6alkylOR5, OC2-6alkylOR5, C1-6alkylSR5, OC2-6alkylSR5, (CO)R5, O(CO)R5, OC2-6alkylcyano, OC1-6alkylCO2R5, O(CO)OR5, OC1-6alkyl(CO)R5, C1-6alkyl(CO)R5, NR5OR6, C0-6NR5R6, OC2-6alkylNR5R6, C0-6alkyl(CO)NR5R6, OC1-6alkyl(CO)NR5R6, OC2-6alkylNR5(CO)R6, C0-6alkylNR5(CO)R6, C0-6alkylNR5(CO)NR5R6, O(CO)NR5R6, C0-6alkyl(SO2)NR5R6, OC2-6alkyl(SO2)NR5R6, C0-6alkylNR5(SO2)R6, OC2-6alkylNR5(SO2)R6, SO3R5, C1-6alkylNR5(SO2)NR5R6, OC2-6alkyl(SO2)R5, C0-6alkyl(SO2)R5, C0-6alkyl(SO)R5, OC2-6alkyl(SO)R5 and a 5- or 6-membered ring containing one or more atoms independently selected from the group consisting of C, N, O and S;
R5 and R6 are independently selected from, H, C1-6alkyl, C3-7cycloalkyl and aryl
and salts and hydrates thereof
m is selected from 1 or 2
p is selected from 0, 1, 2, 3 or 4
or a salt or hydrate thereof;
provided that the compound is not
1-(2-benzothiazolyl)-4-5-(5-methyl-2-furanyl)-2H-tetrazol-2-ylacetyl-piperazine,
1-(4-acetylphenyl)-4-5-(5-methyl-2-furanyl)-2H-tetrazol-2-ylacetyl-piperazine, or
5-(5-methyl-2-furanyl)-N-(2-phenyl-2H-benzotriazol-5-yl)-2H-tetrazole-2-acetamide.
2. A compound according to claim 1 wherein X3 is N and X4 is C.
3. A compound according to claim 1 wherein P is aryl.
4. A compound according to claim 3 wherein P is phenyl.
5. A compound according to claim 1 wherein R1 is selected from halo, C1-6alkyl, \u2014OC1-6alkyl, C0-6alkylcyano.
6. A compound according to claim 5 wherein, R1 is selected from Cl, F, cyano and methyl.
7. A compound according to claim 1 wherein X1 is CR3R4.
8. A compound according to claim 7 wherein X2 is selected from CR3R4, O, S and NR3.
9. A compound according to claim 1 wherein Q is either selected from triazole and piperazine, or else Q is any other 4-, 5-, 6-, or 7-membered heterocyclic ring containing one or more heteroatoms selected from N, O and S and is fused to a triazole ring.
10. A compound according to claim 1 wherein Q is triazole.
11. A compound according to claim 1 wherein X2 is a bond.
12. A compound according to claim 1 wherein Q is piperazine.
13. A compound according to claim 1 wherein Q is a 5-, 6-, or 7-membered heterocyclic ring, other than triazole or piperazine, and is fused to a triazole ring.
14. A compound according to claim 1 wherein R2 is selected from the group consisting of C1-6alkyl, C1-6alkylhalo, C3-7 cylcoalkyl, C0-6alkylaryl, C0-6alkylheteroaryl, O(CO)C1-4alkyl.
15. A compound according to claim 1 wherein R2 is a 5- or 6-membered ring containing one or more atoms independently selected from C, N, O and S, which ring may optionally be fused with a 5- or 6-membered ring containing one or more atoms independently selected from the group consisting of C, N and O and wherein said ring and said fused ring may be substituted by one or more A.
16. A compound according to claim 1 wherein A is selected from the group consisting of halo, \u2014OC1-6alkyl, C0-6NR5R6, C1-6alkylhalo.
17. A compound according to claim 1 selected from:
Ethyl 4-{2-(3-chlorophenyl)-2H-tetrazol-5-ylmethyl}piperazine-1-carboxylate,
4-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-ylmethyl-piperazine-1-carboxylic acid ethyl ester,
4-(2-m-Tolyl-2H-tetrazol-5-ylmethyl)-piperazine-1-carboxylic acid ethyl ester,
4-2-(3-Iodo-phenyl)-2H-tetrazol-5-ylmethyl-piperazine-1-carboxylic acid ethyl ester,
4-2-(3-Cyano-phenyl)-2H-tetrazol-5-ylmethyl-piperazine-1-carboxylic acid ethyl ester,
4-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethyl-piperazine-1-carboxylic acid ethyl ester,
4-5-({2-(3-chlorophenyl)-2H-tetrazol-5-ylmethyl}thio)-4-cyclopropyl-4H-1,2,4-triazol-3-ylpyridine,
4-5-({1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}thio)-4-cyclopropyl-4H-1,2,4-triazol-3-ylpyridine,
Ethyl 4-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}piperazine-1-carboxylate,
4-{5-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-ylmethylsulfanyl-4-methyl-4H-1,2,4triazol-3-yl}-pyridine,
4-{5-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-ylmethylsulfanyl-4-cyclopropyl-4H-1,2,4triazol-3-yl}-pyridine,
4-(5-{1-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-yl-ethylsulfanyl}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
4-(5-{1-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-yl-ethylsulfanyl}-4-cyclopropyl-4H-1,2,4triazol-3-yl)-pyridine,
4-{1-2-(5-Chloro-2-fluoro-phenyl)-2H-tetrazol-5-yl-ethyl}-piperazine-1-carboxylic acid ethyl ester,
4-4-Cyclopropyl-5-(2-m-tolyl-2H-tetrazol-5-ylmethylsulfanyl)-4H-1,2,4triazol-3-yl-pyridine,
4-{4-Cyclopropyl-5-1-(2-m-tolyl-2H-tetrazol-5-yl)-ethylsulfanyl-4H-1,2,4triazol-3-yl}-pyridine,
4-{4-Methyl-5-1-(2-m-tolyl-2H-tetrazol-5-yl)-ethylsulfanyl-4H-1,2,4triazol-3-yl}-pyridine,
3-5-(4-Cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-ylsulfanylmethyl)-tetrazol-2-yl-benzonitrile,
3-{5-1-(4-Cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-ylsulfanyl)-ethyl-tetrazol-2-yl}-benzonitrile
3-{5-1-(4-Methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-ylsulfanyl)-ethyl-tetrazol-2-yl}-benzonitrile-4-{4-Cyclopropyl-5-2-(2-fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethylsulfanyl-4H-1,2,4triazol-3-yl}-pyridine,
4-(4-Cyclopropyl-5-{1-2-(2-fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethylsulfanyl}-4H-1,2,4triazol-3-yl)-pyridine,
4-(5-{1-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethylsulfanyl}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-(2-m-tolyl-2H-tetrazol-5-ylmethyl)amine,
Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-1-(2-m-tolyl-2H-tetrazol-5-yl)ethyl-amine,
2-(3-Chloro-phenyl)-2H-tetrazol-5-ylmethyl-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
{1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethyl}-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethyl-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
{1-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethyl}-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
2-(3-Iodo-phenyl)-2H-tetrazol-5-ylmethyl-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
{1-2-(3-Iodo-phenyl)-2H-tetrazol-5-yl-ethyl}-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-(2-m-tolyl-2H-tetrazol-5-ylmethyl)amine,
Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-1-(2-m-tolyl-2H-tetrazol-5-yl)ethyl-amine,
2-(3-Chloro-phenyl)-2H-tetrazol-5-ylmethyl-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
{1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethyl}-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethyl-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
{1-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethyl}-methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amine,
8-2-(3-Iodo-phenyl)-2H-tetrazol-5-ylmethyl-3-pyridin-4-yl-5,6,7,8-tetrahydro-1,2,4triazolo4,3-apyrimidine,
8-{1-2-(3-Iodo-phenyl)-2H-tetrazol-5-yl-ethyl}-3-pyridin-4-yl-5,6,7,8-tetrahydro-1,2,4triazolo4,3-apyrimidine,
3-Pyridin-4-yl-8-(2-m-tolyl-2H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
3-Pyridin-4-yl-8-1-(2-m-tolyl-2H-tetrazol-5-yl)-ethyl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene, 8-2-(3-Chloro-phenyl)-2H-tetrazol-5-ylmethyl-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene, 8-{1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethyl}-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
8-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethyl-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
8-{1-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethyl}-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
8-2-(3-Iodo-phenyl)-2H-tetrazol-5-ylmethyl-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
8-{1-2-(3-Iodo-phenyl)-2H-tetrazol-5-yl-ethyl}-3-pyridin-4-yl-5,6,7,8-tetrahydro-4H-1,2,3a,8-tetraaza-azulene,
4-(5-{2-(3-chlorophenyl)-2H-tetrazol-5-ylmethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine,
4-(5-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine,
4-4-Methyl-5-(2-m-tolyl-2H-tetrazol-5-ylmethoxy)-4H-1,2,4triazol-3-yl-pyridine,
4-{4-Methyl-5-1-(2-m-tolyl-2H-tetrazol-5-yl)-ethoxy-4H-1,2,4triazol-3-yl}-pyridine,
4-{5-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethoxy-4-methyl-4H-1,2,4triazol-3-yl}-pyridine,
4-(5-{1-2-(2-Fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
4-{5-2-(3-Chloro-phenyl)-2H-tetrazol-5-ylmethoxy-4-cyclopropyl-4H-1,2,4triazol-3-yl}-pyridine,
4-(5-{1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-cyclopropyl-4H-1,2,4triazol-3-yl)-pyridine,
4-4-Cyclopropyl-5-(2-m-tolyl-2H-tetrazol-5-ylmethoxy)-4H-1,2,4triazol-3-yl-pyridine,
4-{4-Cyclopropyl-5-1-(2-m-tolyl-2H-tetrazol-5-yl)-ethoxy-4H-1,2,4triazol-3-yl}-pyridine,
4-{4-Cyclopropyl-5-2-(2-fluoro-5-methyl-phenyl)-2H-tetrazol-5-ylmethoxy-4H-1,2,4triazol-3-yl}-pyridine,
4-(4-Cyclopropyl-5-{1-2-(2-fluoro-5-methyl-phenyl)-2H-tetrazol-5-yl-ethoxy}-4H-1,2,4triazol-3-yl)-pyridine,
4-{5-2-(3-Iodo-phenyl)-2H-tetrazol-5-ylmethoxy-4-methyl-4H-1,2,4triazol-3-yl}-pyridine,
4-(5-{1-2-(3-Iodo-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-methyl-4H-1,2,4triazol-3-yl)pyridine,
4-{4-Cyclopropyl-5-2-(3-iodo-phenyl)-2H-tetrazol-5-ylmethoxy-4H-1,2,4triazol-3-yl}-pyridine,
4-(4-Cyclopropyl-5-{1-2-(3-iodo-phenyl)-2H-tetrazol-5-yl-ethoxy}-4H-1,2,4triazol-3-yl)pyridine,
3-5-(4-Methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yloxymethyl)-tetrazol-2-yl-benzonitrile
3-{5-1-(4-Methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yloxy)-ethyl-tetrazol-2-yl}-benzonitrile,
3-5-(4-Cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yloxymethyl)-tetrazol-2-yl-benzonitrile,
3-{5-1-(4-Cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yloxy)-ethyl-tetrazol-2-yl}-benzonitrile,
3-(5-{Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amino-methyl}-tetrazol-2-yl)-benzonitrile,
3-(5-{1-Methyl-(4-methyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-amino-ethyl}-tetrazol-2-yl)-benzonitrile,
3-5-(3-Pyridin-4-yl-6,7-dihydro-5H-1,2,4triazolo4,3-apyrimidin-8-ylmethyl)-tetrazol-2-yl-benzonitrile,
3-{5-1 (3-Pyridin-4-yl-6,7-dihydro-5H-1,2,4triazolo4,3-apyrimidin-8-yl)-ethyl-tetrazol-2-yl}-benzonitrile,
3-5-(3-Pyridin-4-yl-4,5,6,7-tetrahydro-1,2,3a,8-tetraaza-azulen-8-ylmethyl)-tetrazol-2-yl-benzonitrile,
3-{5-1-(3-Pyridin-4-yl-4,5,6,7-tetrahydro-1,2,3a,8-tetraaza-azulen-8-yl)-ethyl-tetrazol-2-yl}-benzonitrile,
(R) & (S)-4-(5-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine,
2-(3-chloro-phenyl)-5-(triphenyl-\u25a15-phosphanyl)-methyl-2H-tetrazole hydrobromide,
4-(5-{2-2-(3-chloro-phenyl)-2H-tetrazol-5-yl-vinyl}-4-ethyl-4H-1,2,4triazol-3-yl)pyridine,
4-(5-{2-2-(3-chloro-phenyl)-2H-tetrazol-5-yl-vinyl}-4-ethyl-4H-1,2,4triazol-3-yl)pyridine,
1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-2-(4-cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-ethanol,
2-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-1-(4-cyclopropyl-5-pyridin-4-yl-4H-1,2,4triazol-3-yl)-ethanol,
4-(5-{2-2-(3-chloro-phenyl)-2H-tetrazol-5-yl-vinyl}-4-ethyl-4H-1,2,4triazol-3-yl)pyridine,
3-4-Methyl-5-({2-(3-methylphenyl)-2H-tetrazol-5-ylmethyl}thio)-4H-1,2,4-triazol-3-ylbenzonitrile,
5-({5-(3,5-Difluorophenyl)-4-ethyl-4H-1,2,4-triazol-3-ylthio}methyl)-2-(3-methylphenyl)-2H-tetrazole,
3-4-Methyl-5-({1-2-(3-methylphenyl)-2H-tetrazol-5-ylethyl)thio)-4H-1,2,4-triazol-3-ylbenzonitrile,
5-(1-{5-(3,5-Difluorophenyl)-4-ethyl-4H-1,2,4-triazol-3-ylthio}ethyl)-2-(3-methylphenyl)-2H-tetrazole,
6-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)nicotinonitrile,
3-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)pyrazine-2-carbonitrile,
2-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)nicotinonitrile,
1-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}-4-(3-nitropyridin-2-yl)piperazine,
8-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}-3-(3,5-difluorophenyl)-5,6,7,8-tetrahydro1,2,4triazolo4,3-apyrimidine,
8-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}-3-(4-methoxyphenyl)-5,6,7,8-tetrahydro1,2,4triazolo4,3-apyrimidine,
3-(2-Chloro-6-methoxypyridin-4-yl)-8-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}-5,6,7,8-Tetrahydro1,2,4triazolo4,3-apyrimidine,
8-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}-3-(2-methoxypyridin-4-yl)-5,6,7,8-tetrahydro1,2,4triazolo4,3-apyrimidine,
8-{2-(3-Chlorophenyl)-2H-tetrazol-5-ylmethyl}-3-(2-methoxypyridin-4-yl)-5,6,7,8-tetrahydro1,2,4triazolo4,3-apyrimidine,
3-(5-{3-(2-Methoxypyridin-4-yl)-6,7-dihydro1,2,4triazolo4,3-apyrimidine-8(5H)-ylmethyl}-2H-tetrazol-2-yl)benzonitrile,
3-(2-Methoxypyridin-4-yl)-8-{1-2-(3-iodophenyl)-2H-tetrazol-5-ylethyl}-5,6,7,8-tetrahydro1,2,4triazolo4,3-apyrimidine,
3-(5-{1-3-(2-Methoxypyridin-4-yl)-6,7-dihydro1,2,4triazolo4,3-apyrimidin-8(5H)-ylethyl}-2H-tetrazol-2-yl)benzonitrile,
3-(5-{3-(2-Methoxypyridin-4-yl)-5,6,7,8-tetrahydro-9H-1,2,4triazolo4,3-a1,3diazepin-9-ylmethyl}-2H-tetrazol-2-yl)benzonitrile,
3-(5-{3-(2,6-Dimethoxypyrimidin-4-yl)-6,7-dihydro1,2,4triazolo4,3-apyrimidin-8(5H)-ylmethyl}-2H-tetrazol-2-yl)benzonitrile,
(R) 3-(5-{1-3-(2-Methoxypyridin-4-yl)-6,7-dihydro1,2,4triazolo4,3-apyrimidin-8(5H)-ylethyl}-2H-tetrazol-2-yl)benzonitrile,
(S) 3-(5-{1-3-(2-Methoxypyridin-4-yl)-6,7-dihydro1,2,4triazolo4,3-apyrimidin-8(5H)-ylethyl}-2H-tetrazol-2-yl)benzonitrile,
(R) Ethyl 4-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}piperazine-1-carboxylate,
(S) Ethyl 4-{1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}piperazine-1-carboxylate,
(R) Ethyl 4-{1-2-(5-chloro-2-fluorophenyl)-2H-tetrazol-5-ylethyl}piperazine-1-carboxylate,
(S) Ethyl 4-{1-2-(5-chloro-2-fluorophenyl)-2H-tetrazol-5-ylethyl}piperazine-1-carboxylate,
(R) 6-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)nicotinonitrile,
(S) 6-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)nicotinonitrile,
(R) 3-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)pyrazine-2-carbonitrile,
(S) 3-(4-{1-2-(3-Chlorophenyl)-2H-tetrazol-5-ylethyl}piperazin-1-yl)pyrazine-2-carbonitrile,
4-(5-{(S)-1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
2-(3-Chloro-phenyl)-5-{(R)-1-5-(3,5-difluoro-phenyl)-4-methyl-4H-1,2,4triazol-3-yloxy-ethyl}-2H-tetrazole,
3-(5-{(R)-1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
4-(5-{2-5-(3-Chlorophenyl)-2H-tetrazol-2-ylpropyl}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine,
4-(5-{(R)-1-2-(3-Chloro-phenyl)-2H-tetrazol-5-yl-ethoxy}-4-methyl-4H-1,2,4triazol-3-yl)-pyridine,
2-(3-chlorophenyl)-5-1-methyl-2-phenylvinyl-2H-tetrazole, and
2-({1-2-(3-chlorophenyl)-2H-tetrazol-5-ylethyl}thio)-imidazo4,5-bpyridine.
18. A pharmaceutical composition comprising as active ingredient a therapeutically effective amount of the compound according to any one of claims 1 to 17, in association with one or more pharmaceutically acceptable diluents, excipients andor inert carriers.
19. (canceled)
20. The compound according to claim 1, for use in therapy.
21. The compound according to claim 1, for use in treatment of mGluR 5 mediated disorders.
22. Use of the compound according to claim 1, in the manufacture of a medicament for the treatment of mGluR 5 mediated disorders.
23. A method of treatment of mGluR 5 mediated disorders, comprising administering to a mammal, including man in need of such treatment, a therapeutically effective amount of the compound according to claim 1.
24. The method according to claim 23, for use in treatment of neurological disorders.
25. The method according to claim 23, for use in treatment of psychiatric disorders.
26. The method according to claim 23, for use in treatment of chronic and acute pain disorder.
27. The method according to claim 23, for use in treatment of gastrointestinal disorders.
28. A method for inhibiting activation of mGluR 5 receptors, comprising treating a cell containing said receptor with an effective amount of the compound according to claim 1.